GENERIC NAME: FLECAINIDE - ORAL (fleck-UH-nide)

BRAND NAME(S): Tambocor

Warning | Medication Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage | Medical Alert

WARNING: This medication infrequently produces very serious, new irregular heartbeats (arrhythmias). Therefore, it should be used in carefully selected patients to treat life-threatening irregular heartbeats only. Consult your doctor or pharmacist for more information.

USES: This medication is used to treat irregular heart rhythms (arrhythmias) and maintain a normal heart rate.

HOW TO USE: This medication may be taken without regard to meals. This medication works best when there is a constant level of the drug in your body. To do this, take each dose exactly as prescribed at evenly spaced intervals, usually every twelve (12) hours. Try to take each dose at the same time each day. Do not stop taking this medication or change the dose without first consulting your doctor. Some conditions may become worse when the drug is suddenly stopped.

SIDE EFFECTS: Constipation, loss of appetite, nausea, vomiting, dizziness, headache, skin rash, blurred vision, anxiety, depression or stomach upset may occur as your body adjusts to the medication. If these effects persist or worsen, inform your MD. Because this medication may cause lightheadedness or dizziness in some people, make sure you know how you react to this drug before driving or operating machinery. Notify your doctor if you develop: chest pain, irregular heartbeat, trembling or shaking, shortness of breath, swelling of feet or lower legs. If you notice other effects not listed above, contact your doctor or pharmacist.

PRECAUTIONS: Be sure your doctor or dentist knows your complete medical history especially if you are planning to undergo any medical or dental procedures. This medication should be used only when clearly needed during pregnancy. It is not known if this medication appears in breast milk. Consult with your doctor before breast-feeding.